Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -173,418 | -54,369 | -68,701 | -55,569 | -65,146 |
| Depreciation Amortization | 2,362 | 793 | 716 | 743 | 633 |
| Accounts receivable | -31,496 | N/A | N/A | N/A | N/A |
| Other Working Capital | -5,737 | -13,898 | -10,874 | 5,368 | -2,113 |
| Other Operating Activity | 86,086 | 17,252 | 18,997 | 16,204 | 21,550 |
| Operating Cash Flow | $-122,203 | $-50,222 | $-59,862 | $-33,254 | $-45,076 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 9,792 |
| PPE Investments | -580 | N/A | -29 | -12 | -82 |
| Investing Cash Flow | $-580 | $N/A | $-29 | $-12 | $9,710 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 100,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 122,500 | 38,708 | 10,000 | N/A | N/A |
| Debt Repayment | N/A | N/A | -5,850 | N/A | N/A |
| Common Stock Issued | 102,904 | 58,858 | 151,169 | 733 | 200,156 |
| Other Financing Activity | -74,625 | -4,697 | -14,501 | -6,850 | -7,813 |
| Financing Cash Flow | $250,779 | $92,869 | $140,818 | $-6,117 | $192,343 |
| Exchange Rate Effect | -11 | 1,298 | -1,480 | -223 | 581 |
| Beginning Cash Position | 271,772 | 227,827 | 148,380 | 187,986 | 30,428 |
| End Cash Position | 399,757 | 271,772 | 227,827 | 148,380 | 187,986 |
| Net Cash Flow | $127,985 | $43,945 | $79,447 | $-39,606 | $157,558 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122,203 | -50,222 | -59,862 | -33,254 | -45,076 |
| Capital Expenditure | -580 | N/A | -29 | -12 | -82 |
| Free Cash Flow | -122,783 | -50,222 | -59,891 | -33,266 | -45,158 |